Comment on Mahmood, M.N. Direct Immunofluorescence of Skin and Oral Mucosa: Guidelines for Selecting the Optimum Biopsy Site. <i>Dermatopathology</i> 2024, <i>11</i>, 52-61. [PDF]
Demiral Ş, Özcan Y, Gamsızkan M.
europepmc +1 more source
Severe cutaneous adverse reactions to anti-osteoporosis drugs: a real-world pharmacovigilance study using the FDA Adverse Event Reporting System database and a review of published cases. [PDF]
Li JW, Lei XD, Dai B.
europepmc +1 more source
Bullous Systemic Lupus Erythematosus As the Initial Presentation of Systemic Lupus Erythematosus. [PDF]
Kydyralieva C.
europepmc +1 more source
Sociodemographic Disparities in Pediatric Dermatological Conditions: Insights From the 2019 Global Burden of Disease Project. [PDF]
Mackenzie E +5 more
europepmc +1 more source
Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report. [PDF]
Izadian Bidgoli A +5 more
europepmc +1 more source
Cutaneous Rosai-Dorfman-Destombes disease: the diagnostic value of the yellow island sign. [PDF]
El Maati M +4 more
europepmc +1 more source
A Clinico-Epidemiological Study of Various Autoimmune Vesiculobullous Disorders in a Tertiary Care Center. [PDF]
Sri Koulini V +3 more
europepmc +1 more source
A case of bullous pemphigoid in an ulcerative colitis patient treated with vedolizumab. [PDF]
Odom MB +3 more
europepmc +1 more source
Two case reports of rare cocaine-associated dermatoses: Pyoderma gangrenosum and linear IgA bullous dermatosis. [PDF]
Cino D +3 more
europepmc +1 more source
Evaluation of Thermal, Hematohistological, and Dermatological Biocompatibility of LED Devices for Neonatal Phototherapy. [PDF]
Nascimento TF +11 more
europepmc +1 more source

